Translational Control of Cell Cycle and Differentiation news

<p>José Lucas and Raúl Méndez, in front of a mural of neurons at the Institute for Research in Biomedicine. Photo: Xavier Cervera, La Vanguardia</p>
18 Feb 2019

La Vanguardia newspaper has interviewed Raúl Méndez, a researcher at IRB Barcelona, and José J. Lucas, from the Severo Ochoa Molecular Biology Center of the CSIC, about the study related to autism and that iscompeting for the Vanguardia de la Ciencia prize: "The fact  that there are environmental factors involved in autism does not mean that vaccines are one of these environmental factors. The alleged relation between childhood vaccination and autism has no basis. CPEB4 influences the development of the nervous system especially during the prenatal stage, and children do not receive vaccines before they are born, "said Raúl Méndez.

Link to...

<p>Raúl Méndez, IRB Barcelona & José J. Lucas, CSIC. Picture by Xavier Cervera, La Vanguardia.</p>
30 Jan 2019

The research focuses on the CPEB4 protein, a key molecule in the development of this neurological disorder.

The award is a joint initiative of La Vanguardia and the Fundació Catalunya-La Pedrera.

<p>Raúl Méndez, IRB Barcelona & José J. Lucas, CSIC. Picture by Xavier Cervera, La Vanguardia.</p>
25 Jan 2019

La Vanguardia has published an article about a research project led by IRB Barcelona and the Severo Ochoa Molecular Biology Centre that has been nominated for the "Vanguardia de la Ciencia" Award. Addressing the CPEB4 protein, the study reveals that it is a key factor in the origin of autism. The winning project will be chosen through a popular vote. The last day to vote is 28 February.

Link to La Vanguardia

<p>Biennal Ciutat i Ciència</p>
16 Jan 2019

From 7 to 11 February, the general public will have the opportunity to participate in activities related to ageing, nanoscience and climate change, among others.

IRB Barcelona will be taking part in the Biennal event through three initiatives that target the public.

<p>Image: CSIC</p>
20 Aug 2018

El Independiente, Catalunya Ràdio and La Vanguardia have interviewed Raúl Méndez, ICREA researcher at IRB Barcelona, to learn more about the recently published study on autism. Méndez points out that despite the importance of the discovery, "we are 'far away' from achieving a cure or solution to the autism spectrum disorder, although it will allow us to focus future studies in this direction."

Link to El Independiente

Link to...

<p>Source: Unsplash</p>
17 Aug 2018

RTVE, Ara, 20 Minutos, Daily Mail, Jornal Médico, Sic Noticias, among other national and international media, have published articles about a recent study on autism. Researchers co-led by Raúl Méndez, head of the Translational Control of Cell Cycle and Differentiation Lab at IRB Barcelona, have discovered that the protein CPEB4, a molecule that regulates protein synthesis, is impaired in most cases of autism.

Link to RTVE

Link to...

<p>Raúl Méndez and Eulàlia Belloc from the Translational Control of Cell Cycle and Differentiation Lab at IRB Barcelona</p>
16 Aug 2018

The protein CPEB4, which coordinates the expression of hundreds of genes required for neuronal activity, is altered in the brains of individuals with autism

Published in Nature, the study indicates that a defect in CPEB4 could be the link between environmental factors that alter brain development and the genes that determine susceptibility to autism

8 Jun 2018

The Asociación Española Contra el Cáncer (AECC) presents a prize for a study that reveals the capacity of the CPEB4 protein to prevent fatty liver disease.

The research was led by Raúl Méndez from IRB Barcelona and Mercedes Fernández from IDIBAPS.

<p>Gonzalo Fernández-Miranda, Project Leader and associate researcher with the Translational Control of Cell Cycle and Differentiation Lab. Image: CaixaImpulse.</p>
22 Dec 2017

El Plural has published an article on the project being undertaken by Gonzalo Fernández-Miranda, an associate researcher at IRB Barcelona. The project seeks to develop a better treatment for cancer of the head and neck by means of an immunotherapeutic approach, which has been validated with proof of concept tests at the genetic level.

Link to El Plural

12 Sep 2017

The only one of its kind in Spain, the Master offers practical training in experimental research in various disciplines at centers of excellence including IRB Barcelona.